Similar articles

• Controlling chirality in enzymatic synthesis.

  Hodgson J. Hodgson J. Biotechnology (N Y). 1992 Oct;10(10):1093-7. doi: 10.1038/nbt1092-1093. Biotechnology (N Y). 1992. PMID: 1368788 No abstract available.
• A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.

  Miller CP, Ullrich JW. Miller CP, et al. Chirality. 2008 Jun;20(6):762-70. doi: 10.1002/chir.20520. Chirality. 2008. PMID: 18200591 Review.
• Chirality and its importance in drug development: an analytical chemist's perspective.

  Fell AF, Ley GW. Fell AF, et al. Biochem Soc Trans. 1991 Apr;19(2):454-6. doi: 10.1042/bst0190454. Biochem Soc Trans. 1991. PMID: 1889628 Review. No abstract available.
• Biocatalysis: synthesis of chiral intermediates for drugs.

  Patel RN. Patel RN. Curr Opin Drug Discov Devel. 2006 Nov;9(6):741-64. Curr Opin Drug Discov Devel. 2006. PMID: 17117684 Review.
• Selective optimization of side activities: another way for drug discovery.

  Wermuth CG. Wermuth CG. J Med Chem. 2004 Mar 11;47(6):1303-14. doi: 10.1021/jm030480f. J Med Chem. 2004. PMID: 14998318 Review. No abstract available.